About In-Med Prognostics L3C
InMed Prognostics Inc. (InMed.AI) is a pioneer in AI-driven predictive analytics for precision neuroimaging, operating across India, Africa, the Middle East, and the USA. The company develops fully automated, organ-agnostic imaging platforms using multi-modal data including text, signal, and image analysis (US Patent No. 11263749). Their flagship product, NeuroShield MR Volumetry, is the world's first brain volumetry tool providing ethnicity-specific reference ranges adjusted to age, gender, and ethnicity, bringing precision medicine to neurodegenerative disease management. The platform has been rigorously validated with 280 subjects and cleared by the US FDA as a clinical decision-support tool. InMed's comprehensive product suite includes NeuroShield CT TBI for neurotrauma screening and quantification, NeuroFlo for neurology workflow optimization, and VivoShield Sports for whole-body MRI athletic wellness assessment. The company serves 220+ clinical sites worldwide with cloud-based solutions that are multi-scanner compatible and validated across 1.5T and 3T scanners from multiple manufacturers. Founded by Dr. Latha Poonamallee, InMed is expanding its portfolio into CT Brain applications, whole body MRI wellness solutions, and lesion detection for pancreatic and liver cancer. The company's mission is to make affordable, accessible healthcare tools available to everyone, everywhere, believing that investing in healthcare is investing in our collective human future.
Mission & Story
Mission
We believe that investing in healthcare is investing in our collective human future and that technology is a great lever to move towards precision health to extend quality of life.
Founding Story
Founded by Dr. Latha Poonamallee (Ph.D., Case Western Reserve University), a pioneer in AI-driven predictive analytics and precision medicine. Co-founded with Rajesh Kumar Purushottam (Ph.D., Stanford University), who brings deep expertise in building and deploying fully automated image processing algorithms and AI/ML pipelines at clinical scale.
Clinical Focus
Medical conditions and clinical areas addressed by In-Med Prognostics L3C.
Who It Serves
Milestones & Awards
Recent Milestones
US FDA 510(k) clearance (K220034) for NeuroShield MR Volumetry. Expanding product portfolio into CT Brain applications, Whole Body MRI wellness and athletic solutions, and lesion detection for pancreatic and liver cancer. Deployed at 220+ clinical sites worldwide.
Awards & Recognition
World's first brain volumetry tool with ethnicity-specific reference ranges. US Patent No. 11263749 for organ-agnostic imaging platform.
Company Details
- Headquarters
- Pune, Maharashtra, India
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.